Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Heise

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Journal of Diabetes Science and Technology|September 27, 2017
Day-to-Day and Within-Day Variability in Glucose-Lowering Effect Between Insulin Degludec and Insulin Glargine (100 U/mL and 300 U/mL): A Comparison Across StudiesTim Heise, Kadriye Kaplan, Hanne L Haahr
Diabetes, Obesity & Metabolism|September 13, 2024
Absence of a glucose-lowering effect in glucose clamp procedures with a long-acting insulin analogueJ Hans DeVries, Sascha Heckermann, Tim Heise
Diabetes, Obesity & Metabolism|November 15, 2019
Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL-1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitusTim Heise, Charles Donnelly, Abhijit Barve, et al.
Journal of Diabetes Science and Technology|February 10, 2021
New Clamp-PID Algorithm for Automated Glucose Clamps Improves Clamp QualityCarsten Benesch, Mareike Kuhlenkötter, Leszek Nosek, et al.
Deutsche Medizinische Wochenschrift (1946)|July 21, 2025
[Type 1 Diabetes and Sports: What to Consider?]Johanna Kramme, Othmar Moser, Tim Heise, et al.
Journal of Diabetes Science and Technology|June 14, 2013
Common standards of basal insulin titration in type 2 diabetesSabine Arnolds, Tim Heise, Frank Flacke, et al.
Diabetes Technology & Therapeutics|August 24, 2004
Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulinChristoph Kapitza, Marcus Hompesch, Birgitte Scharling, et al.
Diabetes Technology & Therapeutics|September 27, 2003
Hypoglycemia warning signal and glucose sensors: requirements and conceptsTim Heise, Theodor Koschinsky, Lutz Heinemann, et al.
Current Medical Research and Opinion|May 25, 2017
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practiceJennifer Goldman, Christoph Kapitza, Jeremy Pettus, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Inhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetesKlaus Rave, Tim Heise, Lutz Heinemann, et al.
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Journal of Diabetes Science and Technology|September 27, 2017
Day-to-Day and Within-Day Variability in Glucose-Lowering Effect Between Insulin Degludec and Insulin Glargine (100 U/mL and 300 U/mL): A Comparison Across StudiesTim Heise, Kadriye Kaplan, Hanne L Haahr
Diabetes, Obesity & Metabolism|September 13, 2024
Absence of a glucose-lowering effect in glucose clamp procedures with a long-acting insulin analogueJ Hans DeVries, Sascha Heckermann, Tim Heise
Diabetes, Obesity & Metabolism|November 15, 2019
Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL-1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitusTim Heise, Charles Donnelly, Abhijit Barve, et al.
Journal of Diabetes Science and Technology|February 10, 2021
New Clamp-PID Algorithm for Automated Glucose Clamps Improves Clamp QualityCarsten Benesch, Mareike Kuhlenkötter, Leszek Nosek, et al.
Deutsche Medizinische Wochenschrift (1946)|July 21, 2025
[Type 1 Diabetes and Sports: What to Consider?]Johanna Kramme, Othmar Moser, Tim Heise, et al.
Journal of Diabetes Science and Technology|June 14, 2013
Common standards of basal insulin titration in type 2 diabetesSabine Arnolds, Tim Heise, Frank Flacke, et al.
Diabetes Technology & Therapeutics|August 24, 2004
Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulinChristoph Kapitza, Marcus Hompesch, Birgitte Scharling, et al.
Diabetes Technology & Therapeutics|September 27, 2003
Hypoglycemia warning signal and glucose sensors: requirements and conceptsTim Heise, Theodor Koschinsky, Lutz Heinemann, et al.
Current Medical Research and Opinion|May 25, 2017
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practiceJennifer Goldman, Christoph Kapitza, Jeremy Pettus, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Inhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetesKlaus Rave, Tim Heise, Lutz Heinemann, et al.
Pageof 15